Upregulation of mitochondrial function is associated with advanced prostate cancer

1 Abstract: Background: The mitochondrial metabolism in prostate cancer (PCa) is of great importance due the unique metabolic shift from glycolysis to oxidative phosphorylation. In this study, we aimed to analyze the expression level of mitochondrial markers TOM20, DRP1 and OPA1 in benign and malig...

Full description

Bibliographic Details
Published in:	Advances in Cancer Biology - Metastasis
Main Authors:	Valentin Baumgartner, Thomas Paul Scherer, Ashkan Mortezavi, Niels Rupp, Holger Moch, Peter Wild, Susanne Dettwiler, Miriam Wanner, Dominik Enderlin, Souzan Salemi, Daniel Eberli
Format:	Article
Language:	English
Published:	Elsevier 2025-03-01
Subjects:	Prostate cancer Mitochondria Tissue microarray Gleason
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667394024000182

Similar Items

Analysis of Mitochondrial Function in Cell Membranes as Indicator of Tissue Vulnerability to Drugs in Humans
by: Ane Elexpe, et al.
Published: (2022-04-01)

Correlation between Gleason Scores of Prostatic Biopsies and Radical Prostatectomy Specimens
by: Panitta Sitthinamsuwan, et al.
Published: (2009-01-01)

Clinical Predictors and Risk Factors of Gleason Score Upgrade: A Retrospective Cohort Analysis
by: Carmine Sciorio, et al.
Published: (2025-05-01)

Correlation of Immunohistochemical Expression of Alpha-Methyl Acyl-Coenzyme A Racemase/p504s with Gleason Grade and Serum PSA Level in Prostate Carcinoma
by: Hina J. Gami, et al.
Published: (2025-01-01)

Serum total prostate-specific antigen (tPSA): correlation with diagnosis and grading of prostate cancer in core needle biopsy
by: Nina Čamdžić, et al.
Published: (2021-02-01)

Misanian Men, are or aren't a Prostatic Adenocarcinoma?
by: Haider Qasim Alhelfi
Published: (2021-04-01)

Should localized prostate cancer in the favourable group no longer be treated?
by: Kamel Hamizi, et al.
Published: (2022-01-01)

Evaluation of specific lncRNAs, miRNAs, and mRNAs in different groups of prostate cancer
by: Gelareh Vahabzadeh, et al.
Published: (2025-01-01)

OVERALL AND CANCER-SPECIFIC SURVIVAL OF HIGH-RISK PROSTATE CANCER – IMPACT OF ADJUVANT THERAPY AFTER RADICAL PROSTATECTOMY
by: Tosho Ganev
Published: (2023-10-01)

Global analysis of the glycoproteome in Saccharomyces cerevisiae reveals new roles for protein glycosylation in eukaryotes
by: Li A Kung, et al.
Published: (2009-09-01)

Inflammatory and mitochondrial gene expression data in GPER-deficient cardiomyocytes from male and female mice
by: Hao Wang, et al.
Published: (2017-02-01)

Clinicopathological Profile of Prostate Cancer Patients: A 10 years Retrospective Study from a Tertiary Care Centre, North East India
by: Stephen Lalfakzuala Sailo, et al.
Published: (2022-11-01)

Correlation and diagnostic performance of the prostate-specific antigen level with the diagnosis, aggressiveness, and bone metastasis of prostate cancer in clinical practice
by: Bannakij Lojanapiwat
Published: (2014-09-01)

Impact of tertiary Gleason pattern 5 on prostate cancer aggressiveness: Lessons from a contemporary single institution radical prostatectomy series
by: Zachary B. Koloff, et al.
Published: (2015-01-01)

Upgrading in prostatic cancer: Clinical and pathological parameters that predict the Gleason's scores changes
by: Kaan Karamik, et al.
Published: (2017-07-01)

Association between Nuclear Morphometry Parameters and Gleason Grade in Patients with Prostatic Cancer
by: Kamil Malshy, et al.
Published: (2022-05-01)

Evaluation Expression COX-2 in Prostatic Carcinoma by PCR and Immunohistochemistry and Its Relationship with Gleason Score
by: Maryam Ghiasi, et al.
Published: (2021-05-01)

Second to fourth digit ratio: its relationship with core cancer volume and Gleason score in prostate biopsy
by: Jin Kyu Oh, et al.
Published: (2012-10-01)

Prostatic Carcinoma: Frequency, Pattern and Evaluation of Gleason Grading in Prostate Biopsies
by: Uzma Bukhari, et al.
Published: (2020-09-01)

Prostatic Carcinoma: Frequency, Pattern and Evaluation of Gleason Grading in Prostate Biopsies
by: Uzma Bukhari, et al.
Published: (2020-09-01)

FACTORS PREDICTING A POSSIBLE INCREASE OF GLEASON SCORE AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH WELL-DIFFERENTIATED PROSTATE CANCER
by: B. Lazarov
Published: (2022-06-01)

Immunohistochemistry for Prostate Biopsy—Impact on Histological Prostate Cancer Diagnoses and Clinical Decision Making
by: Philipp Mandel, et al.
Published: (2021-06-01)

Prostate Specific Antigen Level and Gleason Score in Indonesian Prostate Cancer Patients
by: Muhammad Imam Al Kautsar Herawan, et al.
Published: (2024-09-01)

Management and outcomes of Gleason six prostate cancer detected on needle biopsy: A single-surgeon experience over 6 years
by: Brayden March, et al.
Published: (2017-12-01)

The organization of the transcriptional network in specific neuronal classes
by: Kellen D Winden, et al.
Published: (2009-07-01)

Unveiling mitochondria as central components driving cognitive decline in alzheimer's disease through cross-transcriptomic analysis of hippocampus and entorhinal cortex microarray datasets
by: Pajaree Sonsungsan, et al.
Published: (2024-10-01)

Microarray and qPCR Analysis of Mitochondrial Metabolism Activation during Prenatal and Early Postnatal Development in Rats and Humans with Emphasis on CoQ<sub>10</sub> Biosynthesis
by: Jana Krizova, et al.
Published: (2021-05-01)

Current status and future directions of gene expression profiling in Parkinson's disease
by: James G. Greene
Published: (2012-01-01)

Prognostic Significance of the New Prostatic Carcinoma Grade Grouping System vis-àvis Biochemical Recurrence: Experience from a Tertiary Care Centre in Dakshina Kannada District, Karnataka, India
by: Anuradha Calicut Kini Rao, et al.
Published: (2021-07-01)

Smooth muscle spheroids: Superior building blocks for bladder tissue engineering
by: Dafni Planta, et al.
Published: (2024-12-01)

THE PROGNOSTIC VALUE OF BASELINE PSA BLOOD IN THE TREATMENT OF PROSTATE CANCER
by: A. A. Gritskevich, et al.
Published: (2017-02-01)

PSA DENSITY - A MARKER FOR POORLY-DIFFERENTIATED PROSTATE CANCER
by: Tosho Ganev
Published: (2025-02-01)

Histopathological Spectrum of Lesions Observed in Prostate Specimens - An Institutional Experience
by: Surbhi Mahajan, et al.
Published: (2023-10-01)

Clinical and histopathological characteristics of prostate cancer in Erbil city/ Iraq
by: Narin Shakir Mola ahmed, et al.
Published: (2024-12-01)

Deep Radiomic Analysis to Predict Gleason Score in Prostate Cancer
by: Ahmad Chaddad, et al.
Published: (2020-01-01)

Interreader agreement in different PI-RADS systems in multiparametric prostate magnetic resonance imaging: A head-to-head comparison between PI-RADSv2 and v2.1
by: Merve Horoz, et al.
Published: (2021-01-01)

Grading of prostate cancer: Evolution and changing concepts
by: Vijayalaxmi M Dhorigol, et al.
Published: (2022-01-01)

Evaluation of Relationship between CD38 Expression and Gleason Score in Prostatic Carcinoma
by: Mohsen Besharati Rad, et al.
Published: (2023-12-01)

Expression of BAX and Bcl-2 gene in prostate carcinoma and its correlation with gleason score
by: Aiswarya Unnithan, et al.
Published: (2023-01-01)

Evaluating the relationship between human papilloma virus infections, prostate cancer and interleukin-12 levels
by: S. Moradi, et al.
Published: (2025-10-01)